EP Patent

EP4512399A2 — Solid state forms of tafamidis and salts thereof

Assigned to Teva Pharmaceuticals International GmbH · Expires 2025-02-26 · 1y expired

What this patent protects

The present disclosure relates to solid state forms of Tafamidis and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof.

USPTO Abstract

The present disclosure relates to solid state forms of Tafamidis and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4512399A2
Jurisdiction
EP
Classification
—
Expires
2025-02-26
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceuticals International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.